Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

BACKGROUND: One approach to identify patients who meet specific eligibility criteria for target-based clinical trials is to use patient and tumor registries to prescreen patient populations. OBJECTIVE: Here we demonstrate that the Total Cancer Care (TCC) Protocol, an ongoing, observational study, ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin, Eschrich, Steven A, Berglund, Anders, Mitchell, Melissa, Fenstermacher, David, Danaee, Hadi, Dai, Hongyue, Sullivan, Daniel, Trepicchio, William L, Dalton, William S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379017/
https://www.ncbi.nlm.nih.gov/pubmed/28320689
http://dx.doi.org/10.2196/resprot.7289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379017/
https://www.ncbi.nlm.nih.gov/pubmed/28320689
http://dx.doi.org/10.2196/resprot.7289

Ejemplares similares